AMOXAPINE

Post-LOE

amoxapine

Teva

ANDAORALTABLET

Approved

May 1989

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

4/8 — Partial

AMOXAPINE (amoxapine) by Teva is clinical pharmacology amoxapine is an antidepressant with a mild sedative component to its action. Approved for depression, anxiety. First approved in 1989.

Drug data last refreshed 20h ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY Amoxapine is an antidepressant with a mild sedative component to its action. The mechanism of its clinical action in man is not well understood. In animals, amoxapine reduced the uptake of norepinephrine and serotonin and blocked the response of dopamine receptors to dopamine.…

Indications (2)

depression

Worked on AMOXAPINE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.